ATE254458T1 - Antibiotische zusammensetzungen zur behandlung des auges - Google Patents
Antibiotische zusammensetzungen zur behandlung des augesInfo
- Publication number
- ATE254458T1 ATE254458T1 AT99956504T AT99956504T ATE254458T1 AT E254458 T1 ATE254458 T1 AT E254458T1 AT 99956504 T AT99956504 T AT 99956504T AT 99956504 T AT99956504 T AT 99956504T AT E254458 T1 ATE254458 T1 AT E254458T1
- Authority
- AT
- Austria
- Prior art keywords
- eye
- treating
- antibiotic compositions
- antibiotic
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10250698P | 1998-09-30 | 1998-09-30 | |
| US10250498P | 1998-09-30 | 1998-09-30 | |
| PCT/US1999/022622 WO2000018386A2 (en) | 1998-09-30 | 1999-09-29 | Antibiotic compositions for treatment of the eye, ear and nose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE254458T1 true ATE254458T1 (de) | 2003-12-15 |
Family
ID=26799441
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03020587T ATE501732T1 (de) | 1998-09-30 | 1999-09-29 | Antibiotische zusammensetzung, die moxifloxacin enthält, zur behandlung von augen |
| AT99956504T ATE254458T1 (de) | 1998-09-30 | 1999-09-29 | Antibiotische zusammensetzungen zur behandlung des auges |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03020587T ATE501732T1 (de) | 1998-09-30 | 1999-09-29 | Antibiotische zusammensetzung, die moxifloxacin enthält, zur behandlung von augen |
Country Status (18)
| Country | Link |
|---|---|
| EP (5) | EP2269602B1 (de) |
| JP (5) | JP2002525317A (de) |
| KR (1) | KR101463243B1 (de) |
| CN (2) | CN100374114C (de) |
| AR (2) | AR020661A1 (de) |
| AT (2) | ATE501732T1 (de) |
| AU (1) | AU762827B2 (de) |
| BR (1) | BRPI9914151B1 (de) |
| CA (3) | CA2659064A1 (de) |
| CY (3) | CY1111404T1 (de) |
| DE (2) | DE69912972T2 (de) |
| DK (5) | DK2796138T3 (de) |
| ES (4) | ES2519190T3 (de) |
| HK (4) | HK1150756A1 (de) |
| PT (5) | PT2269602E (de) |
| TR (2) | TR200100883T2 (de) |
| TW (1) | TWI222361B (de) |
| WO (1) | WO2000018386A2 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6509327B1 (en) | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
| AR020661A1 (es) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
| US6395746B1 (en) | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
| US6716830B2 (en) | 1998-09-30 | 2004-04-06 | Alcon, Inc. | Ophthalmic antibiotic compositions containing moxifloxacin |
| DE19937116A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
| DE19937115A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon |
| AU776609B2 (en) | 1999-09-24 | 2004-09-16 | Novartis Ag | Topical suspension formulations containing ciprofloxacin and dexamethasone |
| DE19962470A1 (de) * | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
| AU2001261748A1 (en) * | 2000-05-19 | 2001-12-03 | Alcon Laboratories Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
| US6462033B2 (en) | 2000-07-26 | 2002-10-08 | Alcon Universal Ltd. | Process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
| WO2002040028A1 (fr) * | 2000-11-16 | 2002-05-23 | Wakamoto Pharmaceutical Co., Ltd. | Gouttes pour les yeux en gel antibacterien |
| AU2002226926A1 (en) * | 2000-12-20 | 2002-07-01 | Alcon, Inc. | Antifungal compositions containing an antibiotic and one or more amidoamines |
| WO2002049633A2 (en) | 2000-12-20 | 2002-06-27 | Alcon, Inc. | Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
| CN1231218C (zh) | 2001-09-21 | 2005-12-14 | 爱尔康公司 | 药物组合物在制备用于治疗中耳感染的药物中的用途 |
| US7220431B2 (en) | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| WO2006015545A1 (fr) * | 2004-08-11 | 2006-02-16 | Shenzhen Tys R & D Co., Ltd. | Capsule de gelatine de moxifloxacin et procede pour sa preparation |
| EP1784164A4 (de) * | 2004-09-03 | 2008-07-09 | Piedmont Pharmaceuticals Llc | Verfahren zur transmembranbehandlung und vorbeugung von otitis media |
| DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
| CA2587081A1 (en) * | 2004-12-10 | 2006-06-22 | Alcon, Inc. | Compositions for treatment of ear infections |
| CN101317847B (zh) * | 2007-06-06 | 2010-10-13 | 深圳市瑞谷医药技术有限公司 | 一种眼用或耳鼻用药物组合物及其用途 |
| TWI544934B (zh) * | 2008-06-09 | 2016-08-11 | 愛爾康研究有限公司 | 含有氟喹諾酮抗生素藥物之經改良藥學組成物 |
| US8536167B2 (en) * | 2009-07-02 | 2013-09-17 | Alcon Research, Ltd. | Methods for treating ophthalmic, otic, or nasal infections |
| HUE035586T2 (en) * | 2010-01-07 | 2018-05-28 | Univ Minnesota | Methods and Preparations for the Use of Moxifloxacin in the Ears |
| US9138481B2 (en) | 2011-12-06 | 2015-09-22 | Alcon Research, Ltd. | Cellulosic gel composition with improved viscosity stability |
| RU2472507C1 (ru) * | 2012-02-01 | 2013-01-20 | Закрытое акционерное общество "Брынцалов-А" | Водный состав на основе моксифлоксацина для парентерального введения |
| US9504691B2 (en) | 2012-12-06 | 2016-11-29 | Alcon Research, Ltd. | Finafloxacin suspension compositions |
| US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| CN104224802B (zh) * | 2014-09-19 | 2017-12-12 | 南京优科生物医药研究有限公司 | 一种盐酸莫西沙星滴耳剂及其制备方法 |
| RU2595837C2 (ru) * | 2014-09-29 | 2016-08-27 | Открытое Акционерное Общество "Татхимфармпрепараты" | Состав и способ получения глазных капель |
| JP6474913B2 (ja) * | 2015-10-29 | 2019-02-27 | テイカ製薬株式会社 | 外用剤 |
| US20210038612A1 (en) * | 2018-04-03 | 2021-02-11 | Hyderabad Eye Research Foundation | Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics |
| IT201900005280A1 (it) * | 2019-04-05 | 2020-10-05 | Ntc S R L | Composizione otologica |
| CA3182196A1 (en) * | 2020-06-10 | 2021-12-16 | Anthony Sampietro | Compositions and uses in method for post-operative ocular care |
| KR102656260B1 (ko) | 2022-10-14 | 2024-04-09 | 주식회사태준제약 | 목시플록사신을 포함하는 안과용 조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223493A (en) * | 1984-12-28 | 1993-06-29 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
| CA1325382C (en) * | 1988-01-27 | 1993-12-21 | Takahiro Ogawa | Locally administrable therapeutic composition for inflammatory disease |
| DE3906365A1 (de) | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| AU4201189A (en) * | 1988-08-26 | 1990-03-23 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
| JPH085779B2 (ja) * | 1989-09-22 | 1996-01-24 | 杏林製薬株式会社 | フレロキサシン点眼液 |
| JPH03109236A (ja) * | 1989-09-22 | 1991-05-09 | Hoya Corp | 半導体超微粒子分散ガラスの製造方法 |
| TW209865B (de) * | 1992-01-10 | 1993-07-21 | Bayer Ag | |
| EP0639070B2 (de) | 1992-05-06 | 2010-09-08 | Alcon Laboratories, Inc. | Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen |
| DE4424369A1 (de) * | 1994-07-11 | 1996-01-18 | Bayer Ag | Pyrido[3,2,1.i,j][3,1]benzoxazinderivate |
| JPH0892241A (ja) * | 1994-09-22 | 1996-04-09 | Ss Pharmaceut Co Ltd | ５−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤 |
| US5631287A (en) | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| DE69620136T2 (de) * | 1995-06-06 | 2002-08-01 | Bayer Ag | Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen |
| JP3290914B2 (ja) * | 1997-03-17 | 2002-06-10 | 参天製薬株式会社 | 眼組織におけるキノロン系抗菌剤の定量装置 |
| CN1623533A (zh) * | 1997-09-25 | 2005-06-08 | 拜尔公司 | 控释活性化合物的药物制剂 |
| ATE290848T1 (de) | 1998-09-23 | 2005-04-15 | Unilever Nv | Mundpflegemittel |
| AR020661A1 (es) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
| US20020001617A1 (en) * | 2000-05-26 | 2002-01-03 | Chang-Hyun Lee | Rapidly disintegrating tablet and process for the manufacture thereof |
-
1999
- 1999-09-27 AR ARP990104866A patent/AR020661A1/es not_active Application Discontinuation
- 1999-09-29 ES ES10178657.2T patent/ES2519190T3/es not_active Expired - Lifetime
- 1999-09-29 ES ES99956504T patent/ES2207307T3/es not_active Expired - Lifetime
- 1999-09-29 TR TR2001/00883T patent/TR200100883T2/xx unknown
- 1999-09-29 PT PT101764124T patent/PT2269602E/pt unknown
- 1999-09-29 PT PT141763664T patent/PT2796138T/pt unknown
- 1999-09-29 DK DK14176366.4T patent/DK2796138T3/en active
- 1999-09-29 KR KR1020017003377A patent/KR101463243B1/ko active IP Right Review Request
- 1999-09-29 CA CA002659064A patent/CA2659064A1/en not_active Abandoned
- 1999-09-29 PT PT03020587T patent/PT1384478E/pt unknown
- 1999-09-29 TR TR2007/04370T patent/TR200704370T2/xx unknown
- 1999-09-29 EP EP10176412.4A patent/EP2269602B1/de not_active Expired - Lifetime
- 1999-09-29 AT AT03020587T patent/ATE501732T1/de active
- 1999-09-29 DK DK10176412.4T patent/DK2269602T3/en active
- 1999-09-29 BR BRPI9914151-5A patent/BRPI9914151B1/pt not_active IP Right Cessation
- 1999-09-29 DK DK03020587.6T patent/DK1384478T3/da active
- 1999-09-29 JP JP2000571905A patent/JP2002525317A/ja active Pending
- 1999-09-29 ES ES14176366.4T patent/ES2602956T3/es not_active Expired - Lifetime
- 1999-09-29 CA CA002342211A patent/CA2342211C/en not_active Expired - Lifetime
- 1999-09-29 WO PCT/US1999/022622 patent/WO2000018386A2/en active Application Filing
- 1999-09-29 CN CNB2004100973271A patent/CN100374114C/zh not_active Expired - Lifetime
- 1999-09-29 DE DE69912972T patent/DE69912972T2/de not_active Revoked
- 1999-09-29 DK DK10178657.2T patent/DK2301541T3/da active
- 1999-09-29 AU AU13101/00A patent/AU762827B2/en not_active Expired
- 1999-09-29 PT PT101786572T patent/PT2301541E/pt unknown
- 1999-09-29 CA CA2774207A patent/CA2774207A1/en not_active Abandoned
- 1999-09-29 CN CNB998115096A patent/CN1184968C/zh not_active Ceased
- 1999-09-29 EP EP10178657.2A patent/EP2301541B1/de not_active Expired - Lifetime
- 1999-09-29 DK DK99956504T patent/DK1117401T3/da active
- 1999-09-29 EP EP03020587A patent/EP1384478B1/de not_active Expired - Lifetime
- 1999-09-29 PT PT99956504T patent/PT1117401E/pt unknown
- 1999-09-29 AT AT99956504T patent/ATE254458T1/de not_active IP Right Cessation
- 1999-09-29 EP EP99956504A patent/EP1117401B1/de not_active Revoked
- 1999-09-29 DE DE69943287T patent/DE69943287D1/de not_active Expired - Lifetime
- 1999-09-29 EP EP14176366.4A patent/EP2796138B1/de not_active Expired - Lifetime
- 1999-09-29 ES ES10176412.4T patent/ES2526521T3/es not_active Expired - Lifetime
- 1999-11-03 TW TW088116726A patent/TWI222361B/zh not_active IP Right Cessation
-
2002
- 2002-01-02 HK HK11104778.7A patent/HK1150756A1/xx not_active IP Right Cessation
- 2002-01-02 HK HK04102444.4A patent/HK1059572A1/xx unknown
- 2002-01-02 HK HK02100003.3A patent/HK1038691B/zh not_active IP Right Cessation
- 2002-01-02 HK HK11104892.8A patent/HK1150769A1/xx not_active IP Right Cessation
-
2008
- 2008-08-22 JP JP2008213954A patent/JP2009007375A/ja not_active Withdrawn
-
2011
- 2011-04-21 CY CY20111100409T patent/CY1111404T1/el unknown
- 2011-05-12 AR ARP110101646A patent/AR081393A2/es not_active Application Discontinuation
-
2012
- 2012-01-10 JP JP2012002159A patent/JP2012067141A/ja not_active Withdrawn
- 2012-11-02 JP JP2012242519A patent/JP5563041B2/ja not_active Expired - Lifetime
-
2014
- 2014-05-19 JP JP2014103658A patent/JP2014144982A/ja active Pending
- 2014-10-09 CY CY20141100819T patent/CY1115759T1/el unknown
-
2015
- 2015-01-09 CY CY20151100023T patent/CY1115916T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69912972D1 (de) | Antibiotische zusammensetzungen zur behandlung des auges | |
| DE69819786D1 (de) | Biozidzusammensetzungen zur behandlung vom wasser | |
| DE69928542D1 (de) | 5ht2-agoniste zur behandlung des glaukoms | |
| AU4025599A (en) | Compositions comprising anti-microtubule agents for treating or preventing inflammatory diseases | |
| DE69931975D1 (de) | FSH Mimetika zur Behandlung von Infertilität | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60011570D1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
| DK1173059T3 (da) | Fremgangsmåde til forögelse af biologisk virkningsfuldhed af plantebehandlingssammensætninger | |
| DE69806579T2 (de) | Anlage zur behandlung von nahrungsmitteln | |
| DK1130968T3 (da) | Pesticid sammensætning til frøbehandling | |
| DE69936890D1 (de) | Vorrichtung zur Behandlung von Ischämie | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| DE69323303D1 (de) | Zusammensetzungen zur Behandlung des trockenen Auges | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE326842T1 (de) | Zusammensetzung zur saatgutbehandlung | |
| ATE263777T1 (de) | Zusammensetzungen zur behandlung von entzündungsreaktionen | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE69941821D1 (de) | Fluorenthaltende zusammensetzung zur behandlung von oberflächen | |
| DE69905214D1 (de) | Mittel zur Behandlung der Osteoporose | |
| DE60001255D1 (de) | Zusammensetzung zur Behandlung von Polyesterfaser | |
| DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| ATE230741T1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
| DE69916013D1 (de) | Vorderkammerimplantat zur behandlung des phaken auges | |
| PT1100329E (pt) | Composicoes aquosas reguladoras do crescimento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1117401 Country of ref document: EP |
|
| RZN | Patent revoked |